Could personalised cancer vaccines have saved their lives—if developed and deployed sooner?
New Breakthrough Researchers at the Icahn School of Medicine at Mount Sinai have reached a new milestone. They’ve shown that their personalised vaccine, used with an immune checkpoint inhibitor, is safe and can trigger strong immune responses in people with bladder cancer. The Phase 1 study, led by Dr. Nina Bhardwaj and Dr. Matthew Galsky, […]
Continue Reading